| Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. | |
| | |
MedLine Citation:
|
PMID: 12366619 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To determine the association between angiotensin-converting enzyme (ACE) inhibitor therapy and survival of older heart failure patients with conditions perceived by physicians as contraindications to ACE inhibitors. SETTING: Hospital. DESIGN: Retrospective follow-up study. PARTICIPANTS: Hospitalized older heart failure patients with systolic blood pressure of 90 mmHg or less, serum creatinine of 2.5 mg/dL or more, serum potassium of 5.5 mmol/L or more, or severe aortic stenosis. MEASUREMENTS: One-year postdischarge mortality (with and without adjustment for various patient and care characteristics). Logistic regression analyses were used to estimate the effect of the perceived contraindications on subsequent use of ACE inhibitors. Using Cox proportional hazards models, crude and adjusted hazard ratios (HRs) of 1-year mortality with 95% confidence intervals (CIs) were estimated for patients discharged on ACE inhibitors and compared with those without. HRs were estimated for all patients and were repeated after stratifying patients based on the presence of perceived contraindications to ACE inhibitor use. RESULTS: Of the 295 subjects, 52 (18%) had conditions perceived as contraindications, 186 (63%) received ACE inhibitors, and 107 (40%) died within 1 year of discharge. Presence of a perceived contraindication was independently associated with underutilization of ACE inhibitors on discharge (adjusted OR = 0.35, 95% CI = 0.17-0.71). ACE inhibitor prescription at discharge was associated with lower 1-year mortality overall (HR = 0.58, 95% CI = 0.40-0.85) and for the groups of patients with (HR = 0.34, 95% CI = 0.14-0.81) and without (HR = 0.66, 95% CI = 0.42-1.02) perceived contraindications. CONCLUSIONS: ACE inhibitor use was associated with a significant survival benefit in this cohort of hospitalized older heart failure patients with perceived contraindications. |
| | |
Authors:
|
Ali Ahmed; Catarina I Kiefe; Richard M Allman; Richard V Sims; James F DeLong |
Related Documents
:
|
17942779 - Long-term survival of incident hemodialysis patients who are hospitalized for congestiv... 15234409 - Cardiac resynchronization therapy improves central sleep apnea and cheyne-stokes respir... 7428269 - Hypernephroma embolisation--is it worthwhile? 16198899 - Systolic and diastolic functions in elderly patients with and without heart failure. 15374199 - Clinical determinants of long-term mortality in elderly patients with heart disease. 16087139 - Cellular endotoxin desensitization in patients with severe chronic heart failure. 17190919 - Optimizing therapy of seizures in stroke patients. 2084829 - In vivo catabolism of histamine in the human stomach. 15163439 - Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of the American Geriatrics Society Volume: 50 ISSN: 0002-8614 ISO Abbreviation: J Am Geriatr Soc Publication Date: 2002 Oct |
Date Detail:
|
Created Date: 2002-10-07 Completed Date: 2002-12-19 Revised Date: 2008-03-10 |
Medline Journal Info:
|
Nlm Unique ID: 7503062 Medline TA: J Am Geriatr Soc Country: United States |
Other Details:
|
Languages: eng Pagination: 1659-66 Citation Subset: IM |
Affiliation:
|
Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Alabama at Birmingham, USA. aahmed@uab.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors / contraindications, therapeutic use* Female Follow-Up Studies Heart Failure / drug therapy*, mortality Hospitalization Humans Male Patient Discharge / statistics & numerical data Proportional Hazards Models Retrospective Studies Survival Analysis Survival Rate Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effect of comorbid illness on receipt of cancer screening by older people.
Next Document: Bloodstream infection: differences between young-old, old, and old-old patients.